// App-Quantinova.ai

158 : Real-World Effectiveness of Infliximab in the Treatment of Psoriatic Arthritis over 12 Months: The Canadian Experience

Researchers

Presenter

  • Majed Khraishi

Principal Investigators

  • William Bensen

  • Dalton Sholter

  • Brian Hanna

  • Craig Watts

  • Emmanouil Rampakakis

  • John Sampalis

  • May Shawi

  • Susan Otawa

  • Allen Lehman

Medical Centers

  • Kitchener,Canada

  • Street Medical Group, Edmonton,Canada

  • Sainte-Anne-de-Bellevue,Canada

  • McGill University and University of Montreal, Westmount,Canada

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • Rheumatology Health Team, St Josephs Hospital , McMaster University , Hamilton,Canada

  • Nexus Clinical Research, St Johns, NF, Canada

Locations

  • Canada

Companies

  • Janssen Global Servi

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim